Dyne Therapeutics Statistics

Total Valuation

DYN has a market cap or net worth of $1.43 billion. The enterprise value is $726.93 million.

Market Cap	1.43B
Enterprise Value	726.93M

Important Dates

The next estimated earnings date is Tuesday, March 4, 2025, before market open.

Earnings Date	Mar 4, 2025
Ex-Dividend Date	n/a

Share Statistics

DYN has 101.77 million shares outstanding. The number of shares has increased by 45.97% in one year.

Current Share Class	101.77M
Shares Outstanding	101.77M
Shares Change (YoY)	+45.97%
Shares Change (QoQ)	+9.05%
Owned by Insiders (%)	0.31%
Owned by Institutions (%)	84.05%
Float	70.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.02
P/TBV Ratio	2.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.02, with a Debt / Equity ratio of 0.04.

Current Ratio	17.02
Quick Ratio	16.73
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -68.69% and return on invested capital (ROIC) is -43.16%.

Return on Equity (ROE)	-68.69%
Return on Assets (ROA)	-40.35%
Return on Invested Capital (ROIC)	-43.16%
Return on Capital Employed (ROCE)	-43.34%
Revenue Per Employee	n/a
Profits Per Employee	-$2.09M
Employee Count	141
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.39% in the last 52 weeks. The beta is 1.10, so DYN's price volatility has been higher than the market average.

Beta (5Y)	1.10
52-Week Price Change	-38.39%
50-Day Moving Average	18.87
200-Day Moving Average	30.82
Relative Strength Index (RSI)	37.86
Average Volume (20 Days)	2,161,431

Short Selling Information

The latest short interest is 9.56 million, so 9.39% of the outstanding shares have been sold short.

Short Interest	9.56M
Short Previous Month	9.40M
Short % of Shares Out	9.39%
Short % of Float	13.64%
Short Ratio (days to cover)	3.28

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-314.47M
Pretax Income	-257.40M
Net Income	-294.51M
EBITDA	-312.84M
EBIT	-314.47M
Earnings Per Share (EPS)	-$3.51

Full Income Statement

Balance Sheet

The company has $723.67 million in cash and $24.86 million in debt, giving a net cash position of $698.82 million or $6.87 per share.

Cash & Cash Equivalents	723.67M
Total Debt	24.86M
Net Cash	698.82M
Net Cash Per Share	$6.87
Equity (Book Value)	705.54M
Book Value Per Share	6.93
Working Capital	693.13M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$243.04 million and capital expenditures -$1.38 million, giving a free cash flow of -$244.42 million.

Operating Cash Flow	-243.04M
Capital Expenditures	-1.38M
Free Cash Flow	-244.42M
FCF Per Share	-$2.40

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DYN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-45.97%
Shareholder Yield	-45.97%
Earnings Yield	-20.66%
FCF Yield	-17.14%

Analyst Forecast

The average price target for DYN is $50.78, which is 262.46% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$50.78
Price Target Difference	262.46%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2